99 new locations are to come on line Tuesday.
News & Analysis: Rite Aid
The coronavirus didn't exactly have a damaging effect on the pharmacy chain.
Markets are climbing, and earnings reports from these companies have a lot to do with it.
The pharmacy company reported very good Q3 results.
A number of factors, including a rebranding plan, lifted the stock in November.
A formidable competitor is entering the healthcare arena.
You probably shouldn't invest in these healthcare stocks unless you're betting on a turnaround, and soon.
The drop came on the heels of disappointing earnings guidance.
The pharmacy chain operator's good news wasn't enough to outweigh Wall Street's worries about its bottom-line outlook.
If you like to buy stocks after they take a step back, here are three promising investments that have somehow shed at least 20% of their value over the past month.